Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -11.50x is in line with its 3-year average of -11.96x, around the middle of its 3-year range (-71.06x–17.97x).
178.16% below its 12-month average of -4.13x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 17.97x.
INTEREST COVERAGE RATIO
-11.50x
INTEREST COVERAGE RATIO AVG TTM
-4.13x
INTEREST COVERAGE RATIO AVG 3Y
-11.96x
INTEREST COVERAGE RATIO AVG 5Y
-11.96x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-178.16%
CURRENT VS 3Y AVG
+3.85%
CURRENT VS 5Y AVG
+3.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
-80.39%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$45.21M
Interest Coverage Ratio
-11.50x
TTM Avg
-4.13x
3Y Avg
-11.96x
5Y Avg
-11.96x
Market Cap
$45.62M
Interest Coverage Ratio
-10.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.87M
Interest Coverage Ratio
-43.48x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$46.73M
Interest Coverage Ratio
-9.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.51M
Interest Coverage Ratio
0.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$42.12M
Interest Coverage Ratio
N/A
TTM Avg
53.13x
3Y Avg
53.13x
5Y Avg
53.13x
Market Cap
$47.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.21M | -11.50x | -4.13x | -11.96x | -11.96x |
| DarioHealth Corp. (DRIO)vs › | $45.62M | -10.91x | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.85M | -8.80x | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.87M | -43.48x | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $46.73M | -9.08x | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.59M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.51M | 0.79x | 0.59x | 0.59x | 0.59x |
| BioStem Technologies, Inc. (BSEM)vs › | $42.12M | N/A | 53.13x | 53.13x | 53.13x |
| Lite Strategy, Inc. (LITS)vs › | $47.94M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | -23.69x | N/A | N/A | N/A |
Interest Coverage
-11.5x
Debt/Equity
0.00
Current Ratio
2.91
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 17.97x |
| 2026-03-31 | -6.55x |
| 2025-12-31 | -6.88x |
| 2025-09-30 | -11.73x |
| 2025-06-30 | -13.48x |
| 2025-03-31 | -14.24x |
| 2024-12-31 | -16.06x |
| 2024-09-30 | -13.77x |
| 2024-06-30 | -16.60x |
| 2024-03-31 | -17.11x |
| 2023-12-31 | -10.46x |
| 2023-09-30 | -10.28x |
| 2023-06-30 | -6.35x |
| 2023-03-31 | -71.06x |
| 2020-09-30 | -403.53x |
